IL13RA2 and glioma: Recently, an inspiring case report showed regression of all intracranial and spinal tumors for a patient with recurrent multifocal glioblastoma who received CAR T cells targeting glioma-associated antigen interleukin-13 receptor alpha 2 (IL13Rα2).